First-quarter revenues for the IBO Lab Equipment/Consumables Index declined 9.9% to $803.18 million and operating profits fell 9.8% to $245.35 million, while operating margin was unchanged at 30.5% of sales. Unfavorable currency transactions for US companies and reduced R&D spending by customers resulted in lower revenue growth. Biohit Oyj’s first-quarter sales grew 2.0% to €8.3 […]
Poway, CA 7/7/09—Private equity firm Telegraph Hill Partners has purchased a majority stake in NEXUS Biosystems, a provider of automated sample management systems. The majority equity and growth financing will be used to commercialize NEXUS’s new series of -80°C BioStores. Deval Lashkari, PhD, and Glenn Novotny, both partners in Telegraph Hill, will join the company’s […]
Tory, NY 6/6/09—Evident Technologies, a maker of quantum dots, has filed for Chapter 11 reorganization, seeking a $1.35 million debtor in financing package. “Defending a lawsuit in the Eastern District of Texas for patent infringement required us to spend at an unsustainable rate,” said Clinton Ballinger, CEO of Evident Technologies. “The restructuring plan associated with […]
Danvers, MA 7/9/09—Cell Signaling Technology (CST), a manufacturer of antibodies and reagent products, has acquired all the shares of Netherlands-based BIOKÉ BV, its distributor for the Benelux region. Renamed Cell Signaling Technology Europe, the business will begin filling orders effective January 1, 2010. “This acquisition will permit CST to better support its European customers and […]
Lombard, IL 6/25/09—Orochem Technologies, a supplier of sample preparation products for life science, has acquired Oligonet, a custom oligonucleotide synthesis business based in Gaithersburg, Maryland. Financial details were not disclosed. “We saw great synergy between the Orochem and Oligonet products and this acquisition helps us offer a complete line of products to our customers,” stated […]
San Diego, CA 7/1/09—Illumina has revised its forecast for the second quarter and year-end. The company now expects second-quarter revenues of approximately $161 million, compared to guidance of $168–$173 million (see IBO 5/15/09). Full-year revenues are now estimated to be $690–$720 million. Citing a sequential quarterly decline in array revenue for the change, Illumina highlighted […]
The growing volume and complexity of genomic research requires higher-throughput, higher-density techniques that can simultaneously capture multiple data points with greater sensitivity at a lower cost per point. Rare variant research, validation studies and biomarker discovery are among the applications that will directly benefit. Such advancements are also applicable to the development and application of […]
In calendar-year 2008 (CY08), total R&D spending in US dollars for 20 major analytical and life science instrument companies (see table, page 4) climbed 9.5% to $1.41 billion, compared to 10.9% growth in CY07. The median growth rate grew 60 basis points to 8.5% in CY08. The increase in R&D spending was primarily a result […]
Unlike simpler flame and furnace spectrometers, inductively coupled plasma optical emission spectroscopy (ICP) uses plasma to excite atoms in a sample into giving off light. The light can be analyzed by the spectrometer in order to identify and quantify the elements present. The plasma, almost universally made from argon gas, is created by electromagnetic induction. […]
Company Announcements Illumina and Agilent entered into a comarketing agreement in April for their respective Genome Analyzer and SureSelect Target Enrichment System. In March, Luminex settled litigation related to its Molecular Diagnostics business brought by The Research Foundation for the State University of New York and the Board of Trustees of the University of Illinois, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
